- Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15. Fisher, B., Brown, A.M., Dimitrov, N.V., Poisson, R., Redmond, C., Margolese, R.G., Bowman, D., Wolmark, N., Wickerham, D.L., Kardinal, C.G. J. Clin. Oncol. (1990)